// App-Quantinova.ai

EP428 : PROGNOSTIC FACTORS OF OVERALL AND RELAPSE-FREE SURVIVAL FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) IN REMISSION: MULTIVARIATE ANALYSES FROM THE QUAZAR AML-001 TRIAL OF ORAL AZACITIDINE (ORAL-AZA )

Researchers

Presenter

  • Gail Roboz

Principal Investigators

  • Andrew Wei

  • Farhad Ravandi

  • Christopher Pocock

  • Pau Montesinos

  • Herv Dombret

  • Kimmo Porkka

  • Ignazia La Torre

  • Barry Skikne

  • Jianhua Zhong

  • CL Beach

  • Hartmut Dhner

Medical Centers

  • The Alfred Hospital, Melbourne, Australia

  • Pediatric Oncology, Hospital Universitari i Politecnic La Fe, Valencia, Spain

  • Deakin University, Melbourne, Australia

  • Hopital Saint-Louis, Assistance Publique - Hopitaux De Paris (AP-HP), Paris, FRA

  • Universitatsklinikum Ulm, Ulm, Germany

  • Kent & Canterbury Hospital, Kent, United Kingdom

  • University of Texas MD Anderson Cancer Center, Houston, Texas, United States

  • HUS Comprehensive Cancer Center, Hematology Research Unit Helsinki and iCAN Digital Precision Cancer Center Medicine Flagship, University of Helsinki,Helsinki,Finlande

  • Institut de Recherche Saint-Louis, Université de Paris,Paris,France

  • Celgene International Sàrl, a Bristol Myers Squibb Company, Boudry, Switzerland

  • University of Kansas Medical Center, Kansas City, Kansas, United States

  • Pediatrics, Weill Cornell Medical College, New York, New York, United States

  • Bristol Meyers Squibb,Princeton,United States

  • Newyork Presbyterian Hospital, Newyork, New York, United States

  • Kent &amp

Locations

  • Australia

  • Spain

  • France

  • Germany

  • United Kingdom

  • United States

  • Finland

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Alpha-thalassemia myelodysplasia syndrome

  • Acute myelocytic leukemia

Biomarkers

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • Vidaza

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved